CN100497621C - 通过导入notch基因将骨髓基质细胞诱导分化为神经细胞或骨骼肌细胞的方法 - Google Patents
通过导入notch基因将骨髓基质细胞诱导分化为神经细胞或骨骼肌细胞的方法 Download PDFInfo
- Publication number
- CN100497621C CN100497621C CNB038055961A CN03805596A CN100497621C CN 100497621 C CN100497621 C CN 100497621C CN B038055961 A CNB038055961 A CN B038055961A CN 03805596 A CN03805596 A CN 03805596A CN 100497621 C CN100497621 C CN 100497621C
- Authority
- CN
- China
- Prior art keywords
- cell
- bmsc
- neurocyte
- cells
- camp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/42—Notch; Delta; Jagged; Serrate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1352—Mesenchymal stem cells
- C12N2502/1358—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (56)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30003/2002 | 2002-02-06 | ||
JP2002030003A JP3948971B2 (ja) | 2001-08-30 | 2002-02-06 | Notch遺伝子の導入を用いて骨髄間質細胞を神経細胞及び骨格筋細胞に分化・誘導する方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910147488XA Division CN101584869B (zh) | 2002-02-06 | 2003-02-06 | 通过导入notch基因将骨髓基质细胞诱导分化为神经细胞或骨骼肌细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1639335A CN1639335A (zh) | 2005-07-13 |
CN100497621C true CN100497621C (zh) | 2009-06-10 |
Family
ID=27677898
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB038055961A Expired - Lifetime CN100497621C (zh) | 2002-02-06 | 2003-02-06 | 通过导入notch基因将骨髓基质细胞诱导分化为神经细胞或骨骼肌细胞的方法 |
CN200910147488XA Expired - Lifetime CN101584869B (zh) | 2002-02-06 | 2003-02-06 | 通过导入notch基因将骨髓基质细胞诱导分化为神经细胞或骨骼肌细胞的方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910147488XA Expired - Lifetime CN101584869B (zh) | 2002-02-06 | 2003-02-06 | 通过导入notch基因将骨髓基质细胞诱导分化为神经细胞或骨骼肌细胞的方法 |
Country Status (10)
Country | Link |
---|---|
US (7) | US7682825B2 (zh) |
EP (2) | EP1479767B1 (zh) |
CN (2) | CN100497621C (zh) |
AU (1) | AU2003207064B2 (zh) |
CA (1) | CA2475288C (zh) |
DK (1) | DK1479767T3 (zh) |
ES (1) | ES2431518T3 (zh) |
HK (2) | HK1078610A1 (zh) |
PT (1) | PT1479767E (zh) |
WO (1) | WO2003066856A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104519891A (zh) * | 2012-05-16 | 2015-04-15 | 桑比欧公司 | 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物 |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003207064B2 (en) | 2002-02-06 | 2006-07-13 | Sanbio, Inc. | Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring Notch gene |
US20050265983A1 (en) * | 2002-11-17 | 2005-12-01 | Eldad Melamed | Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
EP1619242A4 (en) * | 2003-03-25 | 2006-09-06 | Japan Science & Tech Agency | CONTROL OF INDUCTION OF DIFFERENTIATION OF STEM CELLS AND DIFFERENTIATION CAPACITY |
EP2314674A1 (en) * | 2004-04-12 | 2011-04-27 | SanBio, Inc. | Cells exhibiting neuronal progenitor cell characteristics |
JP4581085B2 (ja) * | 2004-12-24 | 2010-11-17 | 国立大学法人京都大学 | 骨格筋細胞の分化誘導方法 |
US20060216276A1 (en) * | 2005-03-07 | 2006-09-28 | Mari Dezawa | Use of materials for treatment of central nervous system lesions |
GB0504881D0 (en) * | 2005-03-09 | 2005-04-13 | Univ Edinburgh | Directed neural differentiation |
AU2006225986B2 (en) | 2005-03-23 | 2011-09-01 | Qualcomm Incorporated | Method and system for digital pen assembly |
EP2465924A3 (en) | 2005-06-16 | 2013-01-02 | Ramot at Tel-Aviv University Ltd. | Isolated cells and populations comprising same for the treament of cns diseases |
WO2008102460A1 (en) * | 2007-02-23 | 2008-08-28 | Sanbio Inc. | Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury |
JP5662147B2 (ja) * | 2007-08-15 | 2015-01-28 | サンバイオ,インコーポレイティド | 神経変性を治療するための方法及び組成物 |
US10702554B2 (en) | 2007-12-03 | 2020-07-07 | Sanbio, Inc. | Extracellular matrix from pluripotent cells |
EP2222839B1 (en) * | 2007-12-03 | 2015-09-16 | SanBio, Inc. | Methods and compositions for modulating differentiation of pluripotential cells |
CN102027118B (zh) * | 2008-04-30 | 2014-07-30 | 桑比欧公司 | 含有dna甲基化状态改变的神经再生细胞 |
WO2009144718A1 (en) | 2008-05-28 | 2009-12-03 | Ramot At Tel Aviv University Ltd. | Mesenchymal stem cells for the treatment of cns diseases |
CN102666855A (zh) * | 2009-06-10 | 2012-09-12 | 脑干生物技术有限公司 | 用于多能性基质细胞的神经元分化的方法、系统和组合物 |
CN106692193B (zh) | 2011-04-06 | 2021-01-05 | 桑比欧公司 | 用于调节外周免疫功能的方法和组合物 |
US20120263681A1 (en) * | 2011-04-12 | 2012-10-18 | Fujifilm Corporation | Composition comprising cell and biocompatible polymer |
WO2013112917A1 (en) | 2012-01-27 | 2013-08-01 | Sanbio, Inc. | Methods and compositions for modulating angiogenesis and vasculogenesis |
EP3401394A1 (en) | 2012-02-22 | 2018-11-14 | Exostem Biotec Ltd | Generation of neural stem cells |
EP2880151B1 (en) * | 2012-08-06 | 2020-06-03 | Brainstorm Cell Therapeutics Ltd. | Methods of generating mesenchymal stem cells which secrete neurotrophic factors |
JP5856029B2 (ja) * | 2012-08-31 | 2016-02-09 | 阿部 博幸 | 間葉系幹細胞を未分化増殖させる方法、および間葉系幹細胞を濃縮する方法 |
AU2013330433B2 (en) | 2012-10-09 | 2016-06-16 | Sanbio, Inc. | Methods and compositions for treatment of retinal degeneration |
US10564149B2 (en) | 2014-02-11 | 2020-02-18 | Brainstorm Cell Therapeutics Ltd. | Populations of mesenchymal stem cells that secrete neurotrophic factors |
CN111668430A (zh) | 2014-05-13 | 2020-09-15 | 赛尔格有限责任公司 | 功能化的多孔膜及其制造和使用方法 |
JP6663445B2 (ja) | 2015-04-01 | 2020-03-11 | サンバイオ,インコーポレイティド | 細胞増殖の刺激のための方法及び組成物、ならびにfgf2アイソフォームの生物学的に活性な混合物の提供 |
CN106399381B (zh) * | 2015-07-30 | 2019-11-26 | 中国农业大学 | miR-34c在体外诱导骨骼肌细胞分化中的应用 |
CA3030866A1 (en) | 2016-07-21 | 2018-01-25 | Sanbio, Inc. | Msc growth predictor assays |
EP3548114A4 (en) | 2016-12-28 | 2020-07-15 | SanBio, Inc. | CELL RELEASE SYSTEM AND METHOD FOR THE OPERATION THEREOF |
CN111793608B (zh) * | 2017-07-28 | 2022-05-17 | 杨涛 | 定向诱导hiPSC分化为神经细胞体系的HS5条件培养基 |
WO2019073055A1 (en) | 2017-10-13 | 2019-04-18 | Imba - Institut Für Molekulare Biotechnologie Gmbh | ENHANCED REPROGRAMMING OF SOMATIC CELLS |
KR20240012562A (ko) * | 2021-05-27 | 2024-01-29 | 샌바이오, 인크. | 소규모 뇌졸중에 대한 세포 치료법 및 치료 방법 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999056759A1 (en) * | 1998-05-07 | 1999-11-11 | University Of South Florida | Bone marrow cells as a source of neurons for brain and spinal cord repair |
CN1242802A (zh) * | 1996-11-07 | 2000-01-26 | 洛伦蒂斯有限公司 | Notch蛋白及其配体 |
WO2001022978A2 (en) * | 1999-09-30 | 2001-04-05 | Mcgill University | Autologous marrow stem cell (msc) transplantation for myocardial regeneration |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5226914A (en) * | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
DE4138621A1 (de) * | 1991-11-25 | 1993-06-17 | Boehringer Ingelheim Int | Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
US5780300A (en) * | 1995-09-29 | 1998-07-14 | Yale University | Manipulation of non-terminally differentiated cells using the notch pathway |
WO2000017326A1 (en) * | 1998-09-21 | 2000-03-30 | Musc Foundation For Research Development | Non-hematopoietic cells, including cardiomyocytes and skeletal muscle cells, derived from hematopoietic stem cells and methods of making and using them |
US7105150B2 (en) * | 1999-02-12 | 2006-09-12 | Stemcells California, Inc. | In vivo screening methods using enriched neural stem cells |
US7015037B1 (en) * | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
US6555374B1 (en) * | 1999-08-19 | 2003-04-29 | Artecel Sciences, Inc. | Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
ES2292564T3 (es) | 2000-02-11 | 2008-03-16 | Philadelphia Health And Education Corporation | Diferenciacion de celulas de la medula osea en celulas neuronales y usos asociados. |
KR100449141B1 (ko) * | 2001-04-19 | 2004-09-21 | (주)라이프코드 | 간엽 간세포를 신경세포로 분화시키는 방법 |
AU2003207064B2 (en) | 2002-02-06 | 2006-07-13 | Sanbio, Inc. | Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring Notch gene |
US20060216276A1 (en) * | 2005-03-07 | 2006-09-28 | Mari Dezawa | Use of materials for treatment of central nervous system lesions |
JP5662147B2 (ja) * | 2007-08-15 | 2015-01-28 | サンバイオ,インコーポレイティド | 神経変性を治療するための方法及び組成物 |
EP2222839B1 (en) | 2007-12-03 | 2015-09-16 | SanBio, Inc. | Methods and compositions for modulating differentiation of pluripotential cells |
CN102027118B (zh) * | 2008-04-30 | 2014-07-30 | 桑比欧公司 | 含有dna甲基化状态改变的神经再生细胞 |
-
2003
- 2003-02-06 AU AU2003207064A patent/AU2003207064B2/en not_active Expired
- 2003-02-06 EP EP03703224.0A patent/EP1479767B1/en not_active Expired - Lifetime
- 2003-02-06 CN CNB038055961A patent/CN100497621C/zh not_active Expired - Lifetime
- 2003-02-06 EP EP10179969A patent/EP2270146A1/en not_active Ceased
- 2003-02-06 US US10/503,816 patent/US7682825B2/en active Active
- 2003-02-06 CN CN200910147488XA patent/CN101584869B/zh not_active Expired - Lifetime
- 2003-02-06 ES ES03703224T patent/ES2431518T3/es not_active Expired - Lifetime
- 2003-02-06 CA CA2475288A patent/CA2475288C/en not_active Expired - Lifetime
- 2003-02-06 DK DK03703224.0T patent/DK1479767T3/da active
- 2003-02-06 PT PT37032240T patent/PT1479767E/pt unknown
- 2003-02-06 WO PCT/JP2003/001260 patent/WO2003066856A1/ja active Application Filing
-
2005
- 2005-11-18 HK HK05110355.3A patent/HK1078610A1/xx not_active IP Right Cessation
-
2009
- 2009-09-10 US US12/584,657 patent/US8361456B2/en not_active Expired - Lifetime
-
2010
- 2010-02-02 US US12/658,104 patent/US8133725B2/en not_active Expired - Fee Related
- 2010-05-14 HK HK10104703.8A patent/HK1139039A1/xx not_active IP Right Cessation
-
2011
- 2011-09-15 US US13/233,701 patent/US8969078B2/en not_active Expired - Lifetime
-
2013
- 2013-01-03 US US13/733,510 patent/US9399046B2/en active Active
-
2016
- 2016-06-24 US US15/192,671 patent/US10196605B2/en not_active Expired - Lifetime
-
2019
- 2019-01-07 US US16/241,802 patent/US11512284B2/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1242802A (zh) * | 1996-11-07 | 2000-01-26 | 洛伦蒂斯有限公司 | Notch蛋白及其配体 |
WO1999056759A1 (en) * | 1998-05-07 | 1999-11-11 | University Of South Florida | Bone marrow cells as a source of neurons for brain and spinal cord repair |
WO2001022978A2 (en) * | 1999-09-30 | 2001-04-05 | Mcgill University | Autologous marrow stem cell (msc) transplantation for myocardial regeneration |
Non-Patent Citations (4)
Title |
---|
NOTCH SIGNALLING VIA RBP-J PROMOTES MYELOIDDIFFERENTIATION.. SCHROEDER T ET AL.EMBO J.,Vol.19 No.11. 2000 |
NOTCH SIGNALLING VIA RBP-J PROMOTES MYELOIDDIFFERENTIATION.. SCHROEDER T ET AL.EMBO J.,Vol.19 No.11. 2000 * |
PHENOTYPICAL AND FUNCTIONAL PROPERTIES OFHUMAN BONE MARROW MESENCHYMAL PROGENITORCELLS.. PAULETTE A ETAL.JOURNAL OF CELLULAR PHYSIOLOGY,Vol.181 . 1999 |
PHENOTYPICAL AND FUNCTIONAL PROPERTIES OFHUMAN BONE MARROW MESENCHYMAL PROGENITORCELLS.. PAULETTE A ETAL.JOURNAL OF CELLULAR PHYSIOLOGY,Vol.181 . 1999 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104519891A (zh) * | 2012-05-16 | 2015-04-15 | 桑比欧公司 | 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物 |
CN104519891B (zh) * | 2012-05-16 | 2019-03-22 | 桑比欧公司 | 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物 |
Also Published As
Publication number | Publication date |
---|---|
AU2003207064B2 (en) | 2006-07-13 |
US9399046B2 (en) | 2016-07-26 |
CA2475288C (en) | 2014-09-02 |
PT1479767E (pt) | 2013-11-07 |
US20120009160A1 (en) | 2012-01-12 |
DK1479767T3 (da) | 2013-11-25 |
US7682825B2 (en) | 2010-03-23 |
WO2003066856A1 (en) | 2003-08-14 |
CA2475288A1 (en) | 2003-08-14 |
US20160151418A9 (en) | 2016-06-02 |
EP2270146A1 (en) | 2011-01-05 |
AU2003207064A1 (en) | 2003-09-02 |
CN101584869B (zh) | 2013-03-27 |
CN101584869A (zh) | 2009-11-25 |
US10196605B2 (en) | 2019-02-05 |
US20100310523A1 (en) | 2010-12-09 |
US8361456B2 (en) | 2013-01-29 |
EP1479767A4 (en) | 2005-02-16 |
CN1639335A (zh) | 2005-07-13 |
US20130209428A1 (en) | 2013-08-15 |
US20160304835A1 (en) | 2016-10-20 |
US8969078B2 (en) | 2015-03-03 |
US20190136183A1 (en) | 2019-05-09 |
US11512284B2 (en) | 2022-11-29 |
HK1078610A1 (en) | 2006-03-17 |
US20060166362A1 (en) | 2006-07-27 |
EP1479767B1 (en) | 2013-08-21 |
EP1479767A1 (en) | 2004-11-24 |
ES2431518T3 (es) | 2013-11-26 |
US20100144034A1 (en) | 2010-06-10 |
US8133725B2 (en) | 2012-03-13 |
HK1139039A1 (en) | 2010-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100497621C (zh) | 通过导入notch基因将骨髓基质细胞诱导分化为神经细胞或骨骼肌细胞的方法 | |
Dezawa et al. | Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation | |
Pires et al. | Old and new challenges in Parkinson's disease therapeutics | |
EP1737950B9 (en) | Cells exhibiting neuronal progenitor cell characteristics | |
US20100129319A1 (en) | Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor | |
Dezawa et al. | Treatment of neurodegenerative diseases using adult bone marrow stromal cell-derived neurons | |
Dezawa | Insights into autotransplantation: the unexpected discovery of specific induction systems in bone marrow stromal cells | |
Song et al. | A novel approach to facilitate dopaminergic neuron generation from stem-cells: the combination of genetic modification and signaling factors within a three-dimensional perfusion microbioreactor | |
Marques | Exploring the Secretome of Mesenchymal Like Stem Cells for Central Nervous System Regenerative Medicine: A Focus on Parkinson's Disease | |
Kumar | Cell based therapy in Amyotrophic Lateral Sclerosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1078610 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1078610 Country of ref document: HK |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20050713 Assignee: Okonvision biomedical (Shanghai) Co.,Ltd. Assignor: Aokangweishi biomedical (Hong Kong) Co.,Ltd. Contract record no.: X2020990000354 Denomination of invention: Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring NOTCH gene Granted publication date: 20090610 License type: Exclusive License Record date: 20200717 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
CX01 | Expiry of patent term |
Granted publication date: 20090610 |
|
CX01 | Expiry of patent term |